4.2 Article

Whole-genome genotyping of haplotype tag single nucleotide polymorphisms

期刊

PHARMACOGENOMICS
卷 7, 期 4, 页码 641-648

出版社

FUTURE MEDICINE LTD
DOI: 10.2217/14622416.7.4.641

关键词

ASPE; association; genotyping; haplotype; infinium; linkage disequilibrium; SBE; SNP; tag SNP; whole-genome genotyping

向作者/读者索取更多资源

The International HapMap Consortium recently completed gencityping over 3.8 million single nuclecitide polymorphisms (SNPs) in three major populations, and the results of studying patterns of linkage disequilibrium indicate that characterization of 300,000-500,000 tag SNPs is sufficient to provide good genomic coverage for linkage-disequilibrium-based association studies in many populations. These whole-genome association studies will be used to dissect the genetics of complex diseases and pharmacogenomic drug responses. As such, the development of a cost-effective gencityping platform that can assay hundred of thousands of SNPs across thousands of samples is essential. In this review, we describe the development of a whole-genome gencityping (WGG) assay that enables unconstrained SNP selection and effectively unlimited multiplexing from a single sample preparation. The development of WGG in concert with high-density BeadChipS (TM) has enabled the creation of three different high-density SNP gencityping BeadChips: the Sentrix (TM) Human-1 Genotyping BeadChip containing over 109,000 exon-centric SNPs; the HumanHap300 BeadChip containing over 317,000 tag SNPs, and the HumanHap550 Beadchip containing over 550,000 tag SNPs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据